Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma.

MLA

Bandini, Cecilia, et al. “Lysin (K)-Specific Demethylase 1 Inhibition Enhances Proteasome Inhibitor Response and Overcomes Drug Resistance in Multiple Myeloma.” Experimental Hematology & Oncology, vol. 12, no. 1, Aug. 2023, p. 71. EBSCOhost, https://doi.org/10.1186/s40164-023-00434-x.

APA

Bandini, C., Mereu, E., Paradzik, T., Labrador, M., Maccagno, M., Cumerlato, M., Oreglia, F., Prever, L., Manicardi, V., Taiana, E., Ronchetti, D., D’Agostino, M., Gay, F., Larocca, A., Besse, L., Merlo, G. R., Hirsch, E., Ciarrocchi, A., Inghirami, G., … Piva, R. (2023). Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma. Experimental Hematology & Oncology, 12(1), 71. https://doi.org/10.1186/s40164-023-00434-x

Chicago

Bandini, Cecilia, Elisabetta Mereu, Tina Paradzik, Maria Labrador, Monica Maccagno, Michela Cumerlato, Federico Oreglia, et al. 2023. “Lysin (K)-Specific Demethylase 1 Inhibition Enhances Proteasome Inhibitor Response and Overcomes Drug Resistance in Multiple Myeloma.” Experimental Hematology & Oncology 12 (1): 71. doi:10.1186/s40164-023-00434-x.